Context-Stratified HEOR: Why Patient Context Is the Next Competitive Advantage

Healthcare spending continues to rise, but the biggest opportunities to improve outcomes and reduce costs aren't found in population averages. They're found in patient context.

People with the same diagnosis often follow very different clinical journeys. Disease severity, multimorbidity, treatment history, healthcare access, and real-world care pathways all shape outcomes, healthcare utilization, and the value a therapy ultimately delivers.

Our latest Evidence Brief explores Context-Stratified Health Economics and Outcomes Research (HEOR) and why this approach is becoming increasingly important for evidence generation, market access, reimbursement, and payer decision-making. Drawing on real-world evidence and healthcare expenditure data, it examines how understanding patient context can reveal where therapies create the greatest clinical and economic value.

Inside the brief, you'll learn:

• Why healthcare costs are concentrated among a small proportion of patients.

• How patient context influences healthcare value beyond diagnosis alone.

• The growing role of real-world evidence in decision-making.

• How Context-Stratified HEOR can strengthen evidence across the product lifecycle.

Healthcare decisions are becoming more personalized, more data-driven, and more focused on value. The question is no longer where healthcare dollars are spent, but where they create the greatest impact.

Access the full Evidence Brief below:

Download Evidence Brief